SalubrisBio - Crunchbase Company Profile & Funding

Q: Who invested in SalubrisBio?

SalubrisBio is funded by Shenzhen Salubris Pharmaceuticals.

Q: When was the last funding round for SalubrisBio?

SalubrisBio closed its last funding round on obfuscated from a Series A round.

Q: How much funding has SalubrisBio raised to date?

SalubrisBio has raised obfuscated.

Overview

SalubrisBio

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About SalubrisBio

CB Rank

25387

SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.

Founded

obfuscation

Private

Series A

Gaithersburg, Maryland, United States

11-50

www.salubrisbio.com

Biotechnology

Health Care

Pharmaceutical

Funding Rounds

Series A

OBF

obfuscation

Corporate Round

OBF

obfuscation

Corporate Round

OBF

obfuscation

Key People

Alice Drumheller: Vice President Clinical Operations
Past Role: Sensei Biotherapeutics, Vice President of Clinical Operations

Details

Sub-Organization of

Shenzhen Salubris Pharmaceuticals

Legal Name

Salubris Biotherapeutics, Inc

Also Known As

Salubris Biotherapeutics

Operating Status

Active

Company Type

For Profit

About the Company

SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.

Contact Email

SalubrisBio@argotpartners.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

JK07

A recombinant fusion protein targeting heart failure by selectively stimulating the ErbB4 pathway, showing promise in both HFrEF and HFpEF.

JK08

An immunocytokine fusion protein designed to target cancer by combining CTLA-4 and IL-15, currently in Phase 1b/2 trials for solid tumors.

Research & Development

SalubrisBio is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - SalubrisBio	1	obfuscated obfuscation	Shenzhen Salubris Pharmaceuticals	Series A
obfuscated obfuscation	Series A - SalubrisBio	1	obfuscated obfuscation	Shenzhen Salubris Pharmaceuticals	Series A
obfuscated obfuscation	Series A - SalubrisBio	1	obfuscated obfuscation	Shenzhen Salubris Pharmaceuticals	Series A
obfuscated obfuscation	Series A - SalubrisBio	1	obfuscated obfuscation	Shenzhen Salubris Pharmaceuticals	Series A
obfuscated obfuscation	Series A - SalubrisBio	1	obfuscated obfuscation	Shenzhen Salubris Pharmaceuticals	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - SalubrisBio	1	obfuscated obfuscation	Shenzhen Salubris Pharmaceuticals	Series A
obfuscated obfuscation	Series A - SalubrisBio	1	obfuscated obfuscation	Shenzhen Salubris Pharmaceuticals	Series A
obfuscated obfuscation	Series A - SalubrisBio	1	obfuscated obfuscation	Shenzhen Salubris Pharmaceuticals	Series A
obfuscated obfuscation	Series A - SalubrisBio	1	obfuscated obfuscation	Shenzhen Salubris Pharmaceuticals	Series A
obfuscated obfuscation	Series A - SalubrisBio	1	obfuscated obfuscation	Shenzhen Salubris Pharmaceuticals	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Shenzhen Salubris Pharmaceuticals	Yes	Series A - SalubrisBio	—
Shenzhen Salubris Pharmaceuticals	Yes	Series A - SalubrisBio	—
Shenzhen Salubris Pharmaceuticals	Yes	Series A - SalubrisBio	—
Shenzhen Salubris Pharmaceuticals	Yes	Series A - SalubrisBio	—
Shenzhen Salubris Pharmaceuticals	Yes	Series A - SalubrisBio	—